Long-term immunogenicity of influenza vaccine among the elderly: Risk factors for poor immune response and persistence

Vaccine

Volumn 28, Issue 23, 2010, Pages 3929-3935

  Song, Joon Young ^a   Cheong, Hee Jin ^a   Hwang, In Sook ^a   Choi, Won Suk ^a   Jo, Yu Mi ^a   Park, Dae Won ^a   Cho, Geum Joo ^b   Hwang, Taik Gun ^b   Kim, Woo Joo ^a  

^a Korea University College of Medicine   (South Korea)

^b Public Health Center   (South Korea)

Author keywords

Elderly; Immunogenicity; Influenza; Vaccination

Indexed keywords

HEMAGGLUTINATION INHIBITING ANTIBODY; INFLUENZA VACCINE;

ADULT; AGED; ANTIBODY TITER; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DRUG FEVER; ECCHYMOSIS; ELDERLY CARE; ERYTHEMA; FATIGUE; FEMALE; GROUPS BY AGE; HEMAGGLUTINATION INHIBITION TEST; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; INJECTION SITE PAIN; MAJOR CLINICAL STUDY; MALAISE; MALE; MYALGIA; PRIORITY JOURNAL; RISK FACTOR; SEROCONVERSION; SWELLING; VACCINATION REACTION;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; FEMALE; FOLLOW-UP STUDIES; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; REPUBLIC OF KOREA; RISK FACTORS; YOUNG ADULT;

EID: 77952430761     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.03.067     Document Type: Article

References (22)

1. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N., Anderson L.J., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289 (2003) 179-186
2. Fiore A.E., Shay D.K., Haber P., Iskander J.K., Uyeki T.M., Mootrey G., et al. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep 56 (2007) 1-54
3. Kee S.Y., Lee J.S., Cheong H.J., Chun B.C., Song J.Y., Choi W.S., et al. Influenza vaccine coverage rates and perceptions on vaccination in South Korea. J Infect 55 (2007) 273-281
4. Gaillat J., Dennetiere G., Raffin-Bru E., Valette M., and Blanc M.C. Summer influenza outbreak in a home for the elderly: application of preventive measures. J Hosp Infect 70 (2008) 272-277
5. Gasparini R., Pozzi T., Montomoli E., Fragapane E., Senatore F., Minutello M., et al. Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjects. Eur J Epidemiol 17 (2001) 135-140
6. McElhaney J.E., Hooton J.W., Hooton N., and Bleackley R.C. Comparison of single versus booster dose of influenza vaccination on humoral and cellular immune responses in older adults. Vaccine 23 (2005) 3294-3300
7. Skowronski D.M., Tweed S.A., and De Serres G. Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant?. J Infect Dis 197 (2008) 490-502
8. Esser M.T., Marchese R.D., Kierstead L.S., Tussey L.G., Wang F., Chirmule N., et al. Memory T cells and vaccines. Vaccine 21 (2003) 419-430
9. European Committee for Proprietary Medicinal Products (CPMP). Note for guidance on harmonisation of requirements for influenza vaccines. London, UK: The European Agency for the Evaluation of Medicinal Products; 1997 Mar 12. Report No.: CPMP/BWP/214/96.
10. Beyer W.E., Palache A.M., Baljet M., and Masurel N. Antibody induction by influenza vaccines in the elderly: a review of the literature. Vaccine 7 (1989) 385-394
11. Govaert T.M., Thijs C.T., Masurel N., Sprenger M.J., Dinant G.J., and Knottnerus J.A. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 272 (1994) 1661-1665
12. Holland D., Booy R., De Looze F., Eizenberg P., McDonald J., Karrasch J., et al. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. J Infect Dis 198 (2008) 650-658
13. Keitel W.A., Atmar R.L., Cate T.R., Petersen N.J., Greenberg S.B., Ruben F., et al. Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons. Arch Intern Med 166 (2006) 1121-1127
14. Bouman A., Heineman M.J., and Faas M.M. Sex hormones and the immune response in humans. Hum Reprod Update 11 (2005) 411-423
15. Hobson D., Curry R.L., Beare A.S., and Ward-Gardner A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond) 70 (1972) 767-777
16. Potter C.W., and Oxford J.S. Determinants of immunity to influenza infection in man. Br Med Bull 35 (1979) 69-75
17. Smith N.M., Bresee J.S., Shay D.K., Uyeki T.M., Cox N.J., and Strikas R.A. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 55 (2006) 1-42
18. Falsey A.R., Treanor J.J., Tornieporth N., Capellan J., and Gorse G.J. Randomized, double-blind controlled phase III trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older. J Infect Dis 200 (2009) 172-180
19. Song J.Y., Ha S.H., Kee S.Y., Jeong H.W., Cheong H.J., and Kim W.J. Debate on annual influenza vaccination in healthcare workers for the same subtype under the vaccine shortage. J Clin Virol 38 (2007) 149-152
20. McDermott A.B., Cohen S.B., Zuckerman J.N., and Madrigal J.A. Hepatitis B third-generation vaccines: improved response and conventional vaccine non-response-evidence for genetic basis in humans. J Viral Hepat 5 Suppl. 2 (1998) 9-11
21. Jo Y.M., Ki S.Y., Song J.Y., Choi W.S., Kim J.Y., Seo Y.B., et al. Immunogenicity and safety of half dose intradermal injection compared to full dose intramuscular injection of influenza vaccine in healthy adults. Infect Chemother 38 (2006) 259-265
22. Squarcione S., Sgricia S., Biasio L.R., and Perinetti E. Comparison of the reactogenicity and immunogenicity of a split and a subunit-adjuvanted influenza vaccine in elderly subjects. Vaccine 21 (2003) 1268-1274